These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD. Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):9980-5. PubMed ID: 12872001 [Abstract] [Full Text] [Related]
7. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models. Hannan SB, Dräger NM, Rasse TM, Voigt A, Jahn TR. J Neurochem; 2016 Apr 19; 137(1):12-25. PubMed ID: 26756400 [Abstract] [Full Text] [Related]
8. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration. García-León JA, Cabrera-Socorro A, Eggermont K, Swijsen A, Terryn J, Fazal R, Nami F, Ordovás L, Quiles A, Lluis F, Serneels L, Wierda K, Sierksma A, Kreir M, Pestana F, Van Damme P, De Strooper B, Thorrez L, Ebneth A, Verfaillie CM. Alzheimers Dement; 2018 Oct 19; 14(10):1261-1280. PubMed ID: 30036493 [Abstract] [Full Text] [Related]
9. Curcumin improves tau-induced neuronal dysfunction of nematodes. Miyasaka T, Xie C, Yoshimura S, Shinzaki Y, Yoshina S, Kage-Nakadai E, Mitani S, Ihara Y. Neurobiol Aging; 2016 Mar 19; 39():69-81. PubMed ID: 26923403 [Abstract] [Full Text] [Related]
11. Caenorhabditis elegans Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies. Natale C, Barzago MM, Diomede L. Brain Sci; 2020 Nov 11; 10(11):. PubMed ID: 33187241 [Abstract] [Full Text] [Related]
12. Biochemical and biophysical features of disease-associated tau mutants V363A and V363I. De Luigi A, Colombo L, Russo L, Ricci C, Bastone A, Cimini S, Tagliavini F, Rossi G, Cantù L, Del Favero E, Salmona M. Biochim Biophys Acta Proteins Proteom; 2022 Mar 01; 1870(3):140755. PubMed ID: 34999006 [Abstract] [Full Text] [Related]
13. Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model. Guha S, Fischer S, Johnson GVW, Nehrke K. Mol Neurodegener; 2020 Nov 09; 15(1):65. PubMed ID: 33168053 [Abstract] [Full Text] [Related]
14. SUT-1 enables tau-induced neurotoxicity in C. elegans. Kraemer BC, Schellenberg GD. Hum Mol Genet; 2007 Aug 15; 16(16):1959-71. PubMed ID: 17576746 [Abstract] [Full Text] [Related]
17. Tau/MAPT disease-associated variant A152T alters tau function and toxicity via impaired retrograde axonal transport. Butler VJ, Salazar DA, Soriano-Castell D, Alves-Ferreira M, Dennissen FJA, Vohra M, Oses-Prieto JA, Li KH, Wang AL, Jing B, Li B, Groisman A, Gutierrez E, Mooney S, Burlingame AL, Ashrafi K, Mandelkow EM, Encalada SE, Kao AW. Hum Mol Genet; 2019 May 01; 28(9):1498-1514. PubMed ID: 30590647 [Abstract] [Full Text] [Related]
18. Progressive neurodegeneration in C. elegans model of tauopathy. Miyasaka T, Ding Z, Gengyo-Ando K, Oue M, Yamaguchi H, Mitani S, Ihara Y. Neurobiol Dis; 2005 Nov 01; 20(2):372-83. PubMed ID: 16242642 [Abstract] [Full Text] [Related]
20. The role of MSUT-2 in tau neurotoxicity: a target for neuroprotection in tauopathy? Wheeler JM, Guthrie CR, Kraemer BC. Biochem Soc Trans; 2010 Aug 01; 38(4):973-6. PubMed ID: 20658987 [Abstract] [Full Text] [Related] Page: [Next] [New Search]